NCT05169268View on ClinicalTrials.gov

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

October 30, 2025

Study Completion Date

January 31, 2026

Conditions
Schizophrenia and Related DisordersAnxiety Depression
Interventions
DRUG

ARIPiprazole Injection [Abilify]

subject already receiving the combination of Abilify Maintena and Rexulti

DRUG

Brexpiprazole

subject already receiving the combination of Abilify Maintena and Rexulti

Trial Locations (1)

000000

RECRUITING

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER